Lyme Disease Diagnostic Market Size, Share, and Outlook, H2-2025 Report- By Emerging Diagnostic Technology (Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, Nucleic acid Test), By End-User (Hospitals, Dia
Description
Lyme Disease Diagnostic Market Outlook
The global Lyme Disease Diagnostic Market Size is valued at $12.3 Billion in 2025 and is forecast to reach $21.6 Billion in 2032 at a CAGR of 8.4%.
The Lyme Disease Diagnostic Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Lyme Disease Diagnostic Market segments across 22 countries from 2021 to 2032. Key segments covered include By Emerging Diagnostic Technology (Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, Nucleic acid Test), By End-User (Hospitals, Diagnostic Laboratories, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Lyme Disease Diagnostic Market Insights, 2025
In 2025, the Lyme disease diagnostic market is shaped by advances in rapid, accurate detection and increased awareness of tick-borne illnesses. Molecular assays, including PCR-based tests, allow early detection of Borrelia species, improving treatment outcomes. Multiplex serological tests are being developed to distinguish active infection from past exposure, reducing false positives. Point-of-care diagnostic kits are becoming more accessible in endemic regions, supporting timely intervention. Integration with electronic health records (EHRs) enables better patient tracking and epidemiological analysis. Continuous research is focused on biomarker identification for earlier and more reliable diagnosis. Public health initiatives are emphasizing prevention, tick control, and clinician awareness to reduce incidence. Overall, the market reflects a shift toward faster, more precise, and patient-friendly diagnostic solutions.
Five Trends Shaping the Global Lyme Disease Diagnostic Market in 2025 and Beyond
The global Lyme Disease Diagnostic Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Lyme Disease Diagnostic Industry?
The Lyme Disease Diagnostic Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Lyme Disease Diagnostic Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Lyme Disease Diagnostic Market Segment Insights
The Lyme Disease Diagnostic Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Emerging Diagnostic Technology (Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, Nucleic acid Test), By End-User (Hospitals, Diagnostic Laboratories, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Lyme Disease Diagnostic Industry Value Chain
The chapter identifies potential companies and their operations across the global Lyme Disease Diagnostic Industry ecosystem. It assists decision-makers in evaluating global Lyme Disease Diagnostic Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Lyme Disease Diagnostic Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Lyme Disease Diagnostic Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Lyme Disease Diagnostic Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Lyme Disease Diagnostic Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Lyme Disease Diagnostic Market.
Europe Lyme Disease Diagnostic Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Lyme Disease Diagnostic Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Lyme Disease Diagnostic Industry competitiveness. The report analyses the key Lyme Disease Diagnostic Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Lyme Disease Diagnostic Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Lyme Disease Diagnostic Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Lyme Disease Diagnostic Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Lyme Disease Diagnostic Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Lyme Disease Diagnostic Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Lyme Disease Diagnostic Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Bio-Rad Laboratories Inc, Canon U.S. Life Sciences Inc, Covance Inc, GlaxoSmithKline plc, Graphene Frontiers LLC, Immunetics Inc, Roche Diagnostics International AG, T2 Biosystems Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Lyme Disease Diagnostic Market Scope
Leading Segments
By Emerging Diagnostic Technology
Serological TestELISA Western Blot
Urine Antigen Tests
Lymphocytic Transformation Test
Immunofluorescent Staining
Nucleic acid Test
By End-User
Hospitals
Diagnostic Laboratories
Others
Leading Companies
Abbott Laboratories
Bio-Rad Laboratories Inc
Canon U.S. Life Sciences Inc
Covance Inc
GlaxoSmithKline plc
Graphene Frontiers LLC
Immunetics Inc
Roche Diagnostics International AG
T2 Biosystems Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Lyme Disease Diagnostic Market Size is valued at $12.3 Billion in 2025 and is forecast to reach $21.6 Billion in 2032 at a CAGR of 8.4%.
The Lyme Disease Diagnostic Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Lyme Disease Diagnostic Market segments across 22 countries from 2021 to 2032. Key segments covered include By Emerging Diagnostic Technology (Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, Nucleic acid Test), By End-User (Hospitals, Diagnostic Laboratories, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Lyme Disease Diagnostic Market Insights, 2025
In 2025, the Lyme disease diagnostic market is shaped by advances in rapid, accurate detection and increased awareness of tick-borne illnesses. Molecular assays, including PCR-based tests, allow early detection of Borrelia species, improving treatment outcomes. Multiplex serological tests are being developed to distinguish active infection from past exposure, reducing false positives. Point-of-care diagnostic kits are becoming more accessible in endemic regions, supporting timely intervention. Integration with electronic health records (EHRs) enables better patient tracking and epidemiological analysis. Continuous research is focused on biomarker identification for earlier and more reliable diagnosis. Public health initiatives are emphasizing prevention, tick control, and clinician awareness to reduce incidence. Overall, the market reflects a shift toward faster, more precise, and patient-friendly diagnostic solutions.
Five Trends Shaping the Global Lyme Disease Diagnostic Market in 2025 and Beyond
The global Lyme Disease Diagnostic Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Lyme Disease Diagnostic Industry?
The Lyme Disease Diagnostic Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Lyme Disease Diagnostic Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Lyme Disease Diagnostic Market Segment Insights
The Lyme Disease Diagnostic Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Emerging Diagnostic Technology (Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, Nucleic acid Test), By End-User (Hospitals, Diagnostic Laboratories, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Lyme Disease Diagnostic Industry Value Chain
The chapter identifies potential companies and their operations across the global Lyme Disease Diagnostic Industry ecosystem. It assists decision-makers in evaluating global Lyme Disease Diagnostic Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Lyme Disease Diagnostic Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Lyme Disease Diagnostic Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Lyme Disease Diagnostic Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Lyme Disease Diagnostic Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Lyme Disease Diagnostic Market.
Europe Lyme Disease Diagnostic Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Lyme Disease Diagnostic Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Lyme Disease Diagnostic Industry competitiveness. The report analyses the key Lyme Disease Diagnostic Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Lyme Disease Diagnostic Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Lyme Disease Diagnostic Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Lyme Disease Diagnostic Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Lyme Disease Diagnostic Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Lyme Disease Diagnostic Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Lyme Disease Diagnostic Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Bio-Rad Laboratories Inc, Canon U.S. Life Sciences Inc, Covance Inc, GlaxoSmithKline plc, Graphene Frontiers LLC, Immunetics Inc, Roche Diagnostics International AG, T2 Biosystems Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Lyme Disease Diagnostic Market Scope
Leading Segments
By Emerging Diagnostic Technology
Serological Test
Urine Antigen Tests
Lymphocytic Transformation Test
Immunofluorescent Staining
Nucleic acid Test
By End-User
Hospitals
Diagnostic Laboratories
Others
Leading Companies
Abbott Laboratories
Bio-Rad Laboratories Inc
Canon U.S. Life Sciences Inc
Covance Inc
GlaxoSmithKline plc
Graphene Frontiers LLC
Immunetics Inc
Roche Diagnostics International AG
T2 Biosystems Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
199 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Lyme Disease Diagnostic Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Lyme Disease Diagnostic Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Lyme Disease Diagnostic Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Lyme Disease Diagnostic Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Lyme Disease Diagnostic Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Emerging Diagnostic Technology
- Serological Test
- -ELISA
- -Western Blot
- Urine Antigen Tests
- Lymphocytic Transformation Test
- Immunofluorescent Staining
- Nucleic acid Test
- By End-User
- Hospitals
- Diagnostic Laboratories
- Others
- 6. Global Lyme Disease Diagnostic Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Lyme Disease Diagnostic Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Lyme Disease Diagnostic Market Trends and Growth Opportunities
- 6.2.1 North America Lyme Disease Diagnostic Market Outlook by Type
- 6.2.2 North America Lyme Disease Diagnostic Market Outlook by Application
- 6.3 North America Lyme Disease Diagnostic Market Outlook by Country
- 6.3.1 The US Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 6.3.2 Canada Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 6.3.3 Mexico Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 7. Europe Lyme Disease Diagnostic Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Lyme Disease Diagnostic Market Trends and Growth Opportunities
- 7.2.1 Europe Lyme Disease Diagnostic Market Outlook by Type
- 7.2.2 Europe Lyme Disease Diagnostic Market Outlook by Application
- 7.3 Europe Lyme Disease Diagnostic Market Outlook by Country
- 7.3.2 Germany Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 7.3.3 France Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 7.3.4 The UK Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 7.3.5 Spain Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 7.3.6 Italy Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 7.3.7 Russia Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 8. Asia Pacific Lyme Disease Diagnostic Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Lyme Disease Diagnostic Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Lyme Disease Diagnostic Market Outlook by Type
- 8.2.2 Asia Pacific Lyme Disease Diagnostic Market Outlook by Application
- 8.3 Asia Pacific Lyme Disease Diagnostic Market Outlook by Country
- 8.3.1 China Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 8.3.2 India Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 8.3.3 Japan Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 8.3.4 South Korea Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 8.3.5 Australia Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 8.3.6 South East Asia Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 9. South America Lyme Disease Diagnostic Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Lyme Disease Diagnostic Market Trends and Growth Opportunities
- 9.2.1 South America Lyme Disease Diagnostic Market Outlook by Type
- 9.2.2 South America Lyme Disease Diagnostic Market Outlook by Application
- 9.3 South America Lyme Disease Diagnostic Market Outlook by Country
- 9.3.1 Brazil Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 9.3.2 Argentina Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 10. Middle East and Africa Lyme Disease Diagnostic Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Lyme Disease Diagnostic Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Lyme Disease Diagnostic Market Outlook by Type
- 10.2.2 Middle East and Africa Lyme Disease Diagnostic Market Outlook by Application
- 10.3 Middle East and Africa Lyme Disease Diagnostic Market Outlook by Country
- 10.3.1 Saudi Arabia Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 10.3.2 The UAE Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 10.3.4 South Africa Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 10.3.5 Egypt Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Lyme Disease Diagnostic Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Abbott Laboratories
- Bio-Rad Laboratories Inc
- Canon U.S. Life Sciences Inc
- Covance Inc
- GlaxoSmithKline plc
- Graphene Frontiers LLC
- Immunetics Inc
- Roche Diagnostics International AG
- T2 Biosystems Inc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
